Halozyme Therapeutics shares owned by Argent Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Argent Capital Management
from 13F filings
Historical chart of Argent Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Argent Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Halozyme Therapeutics by Argent Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $437k | 8.3k | 52.36 |
2022-03-31 | $246k | 6.2k | 39.87 |
2021-12-31 | $252k | 6.3k | 40.19 |
2021-09-30 | $254k | 6.2k | 40.74 |
2021-06-30 | $285k | 6.3k | 45.35 |
2021-03-31 | $340k | 8.2k | 41.72 |
2020-12-31 | $374k | 8.8k | 42.69 |
2020-09-30 | $610k | 23k | 26.27 |